Health & Wellness

Fangzhou has launched Novo Nordisk’s once-weekly basal insulin/GLP-1 therapy in China, expanding access to innovative diabetes treatment for Chinese patients.

• Reviews Mill Team
• July 20, 2026

Neuronata-R retains conditional approval in South Korea, allowing continued use under specific conditions while further evaluations are ongoing.

• Reviews Mill Team
• July 20, 2026

4DMT announces favorable 2-year results from its PRISM Phase 2b trial in wet AMD, showing promising efficacy and safety data in a broad patient population.

• Reviews Mill Team
• July 19, 2026

Medicare has granted favorable coverage for the iMDx GraftA assay, supporting its wider adoption in the healthcare market, according to official sources.

• Reviews Mill Team
• July 17, 2026

Costco faces a lawsuit over claims related to Orgain protein powder, raising questions about product labeling and consumer safety.

• Reviews Mill Team
• July 9, 2026

The world’s first international patient begins treatment with a new CAR-T cell therapy for solid tumors at Jiahui International Cancer Center, marking a milestone in cancer care.

• Reviews Mill Team
• July 7, 2026

The Supreme Court’s recent decision impacts immigrant protections, prompting concern among nursing homes, factory owners, and immigrant communities about future fallout.

• Reviews Mill Team
• June 27, 2026